Kamiya Biomedical Company

Kamiya Biomedical Company manufactures clinical diagnostics assay reagents, research ELISAs, antibodies, and biochemicals for laboratory and preclinical use. Primary product lines include immunoassay and immunoturbidimetric reagents adapted to most major automated chemistry analyzers (Roche Cobas, Hitachi, Beckman, Olympus, Siemens, Abbott, and others), spanning rheumatoid factor, C-reactive protein, D-dimer, ferritin, immunoglobulins, β-2 microglobulin, microtransferrin, vitamin C, apolipoprotein assays, H. pylori testing, and KL-6 measurement. The company also manufactures thousands of ELISA kits for human research and preclinical/animal testing across 20+ species (mouse, rat, dog, cat, primate, bovine, porcine, avian, and others). Secondary offerings include 1,300+ monoclonal and polyclonal antibodies; 200+ biochemicals (recombinants, substrates, inhibitors, polymerases); and laboratory testing services for lipid and vitamin C analysis. Several assays carry regulatory status for clinical diagnostics (ISO 13485, CE Mark), while others are designated research-use-only in the US. The company also produces animal assay reagents for veterinary diagnostics (dog CRP, cat serum amyloid A) and has developed COVID-19 response reagents. Founded in 1983, Kamiya serves clinical laboratories, research institutions, and preclinical/pharmaceutical development markets. Manufacturing capabilities include custom antibody production, ELISA kit formulation, and reagent adaptation to third-party chemistry analyzer platforms.